Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents

被引:444
作者
Finn, AV
Kolodgie, FD
Harnek, J
Guerrero, LJ
Acampado, E
Tefera, K
Skorija, K
Weber, DK
Gold, HK
Virmani, R
机构
[1] CVPath, Int Registry Pathol, Gaithersburg, MD 20878 USA
[2] Massachusetts Gen Hosp, Cardiac Unit, Dept Internal Med, Boston, MA 02114 USA
[3] Univ Lund Hosp, Heart Lung Div, S-22185 Lund, Sweden
关键词
drugs; pathology; restenosis; stents;
D O I
10.1161/CIRCULATIONAHA.104.508937
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Although effective coverage of challenging coronary lesions has warranted the use of overlapping drug-eluting stents, the histopathological response to stent overlap is unknown. Methods and Results - The arterial reaction to overlapping Cypher or Taxus drug-eluting stents was examined in rabbits with bare metal stents, BxVelocity or Express, serving as controls. Single iliac artery balloon injury was followed by placement of 2 overlapping 3.0-mm-diameter drug-eluting stents or bare metal stents in 60 animals ( mean length of overlap, 9.8 +/- 3.6 mm). Stented arteries were harvested at 28 and 90 days for histology. Overlapped segments exhibited delayed healing compared with proximal and distal nonoverlapping sites at 28 days. Overlapped segments in Taxus stents induced significantly more luminal heterophils/eosinophils and fibrin deposition than Cypher; peristrut giant cell infiltration, however, was more frequent in the latter. Overlapping bare metal stents also showed mild delayed healing compared with nonoverlapped segments, but not to the same extent as drug-eluting stents. Although neointimal thickness within the overlap was similar in 28- and 90-day Cypher stents, there was a significant increase with Taxus (P = 0.03). Conclusions - Compared with bare metal stents, drug-eluting stents further delay arterial healing and promote inflammation at sites of overlap. Taxus stents induced greater fibrin deposition, medial cell loss, heterophils/eosinophils, and late neointimal hyperplasia. Patients receiving overlapping drug-eluting stents need more frequent follow-up than patients with nonoverlapping stents.
引用
收藏
页码:270 / 278
页数:9
相关论文
共 27 条
  • [11] Sirolimus-eluting stent implanted in human coronary artery for 16 months - Pathological findings
    Guagliumi, G
    Farb, A
    Musumeci, G
    Valsecchi, O
    Tespili, M
    Motta, T
    Virmani, R
    [J]. CIRCULATION, 2003, 107 (09) : 1340 - 1341
  • [12] Heldman AW, 2001, CIRCULATION, V103, P2289
  • [13] Analysis of 1-year clinical outcomes in the SIRIUS trial - A randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis
    Holmes, DR
    Leon, MB
    Moses, JW
    Popma, JJ
    Cutlip, D
    Fitzgerald, PJ
    Brown, C
    Fischell, T
    Wong, SC
    Midei, M
    Snead, D
    Kuntz, RE
    [J]. CIRCULATION, 2004, 109 (05) : 634 - 640
  • [14] Twenty-eight-day efficacy and phamacokinetics of the sirolimus-eluting stent
    Klugherz, BD
    Llanos, G
    Lieuallen, W
    Kopia, GA
    Papandreou, G
    Narayan, P
    Sasseen, B
    Adelman, SJ
    Falotico, R
    Wilensky, RL
    [J]. CORONARY ARTERY DISEASE, 2002, 13 (03) : 183 - 188
  • [15] First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis - Immediate and long-term clinical and angiographic outcome
    Liistro, F
    Stankovic, G
    Di Mario, C
    Takagi, T
    Chieffo, A
    Moshiri, S
    Montorfano, M
    Carlino, M
    Briguori, C
    Pagnotta, P
    Albiero, R
    Corvaja, N
    Colombo, A
    [J]. CIRCULATION, 2002, 105 (16) : 1883 - 1886
  • [16] LUNA LG, 1968, HIST STAINING METHOD
  • [17] Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
    McFadden, EP
    Stabile, E
    Regar, E
    Cheneau, E
    Ong, ATL
    Kinnaird, T
    Suddath, WO
    Weissman, NJ
    Torguson, R
    Kent, KM
    Pichard, AD
    Satler, LF
    Waksman, R
    Serruys, PW
    [J]. LANCET, 2004, 364 (9444) : 1519 - 1521
  • [18] Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
    Moses, JW
    Leon, MB
    Popma, JJ
    Fitzgerald, PJ
    Holmes, DR
    O'Shaughnessy, C
    Caputo, RP
    Kereiakes, DJ
    Williams, DO
    Teirstein, PS
    Jaeger, JL
    Kuntz, RE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (14) : 1315 - 1323
  • [19] Physical characterization of controlled release of paclitaxel from the TAXUSTM Express2TM drug-eluting stent
    Ranade, SV
    Miller, KM
    Richard, RE
    Chan, AK
    Allen, MJ
    Helmus, MN
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2004, 71A (04) : 625 - 634
  • [20] The Canadian Study of the Sirolimus-Eluting Stent in the Treatment of Patients With Long De Novo Lesions in Small Native Coronary Arteries (C-SIRIUS)
    Schampaert, E
    Cohen, EA
    Schlüter, M
    Reeves, F
    Traboulsi, M
    Title, LM
    Kuntz, RE
    Popma, JJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (06) : 1110 - 1115